$Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma.$

Critical evaluation of vinflunine in the treatment of refractory metastatic urothelial carcinoma.

Urothelial carcinoma (UC) accounts for 5% to 10% of malignancies in men in Europe and the United States. For locally advanced or metastatic disease, there are two standard firstline chemotherapy regimens: MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) and gemcitabine/cisplatin. For refract...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Morel, A, Talbot, D
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Dove Medical Press Ltd. 2010

Eitemau Tebyg

Second line therapy for metastatic urothelial carcinoma. Clinical case of vinflunine use
gan: A. A. Gritskevich, et al.
Cyhoeddwyd: (2022-06-01)

From clinical trials to the front line: Vinflunine for Treatment of UrothelialCell Carcinoma at the National Cancer Institute of Naples
gan: GAETANO eFACCHINI, et al.
Cyhoeddwyd: (2016-05-01)

Vinflunine in the treatment of bladder cancer
gan: Mark Bachner, et al.
Cyhoeddwyd: (2008-11-01)

A Prospective Study of I.V. Vinflunine in the Treatment of Patients with Advanced or Metastatic Urothelial Carcinoma after Failure of a Platinum-containing Regimen and Biomarker Correlates
gan: Fatma M.A. Abouelkasem, et al.
Cyhoeddwyd: (2022-08-01)

Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01–2014)
gan: Rodolfo Passalacqua, et al.
Cyhoeddwyd: (2017-07-01)

Phase II study of vinflunine in malignant pleural mesothelioma.
gan: Talbot, D, et al.
Cyhoeddwyd: (2007)

Stathmin potentiates vinflunine and inhibits Paclitaxel activity.
gan: Soazig Malesinski, et al.
Cyhoeddwyd: (2015-01-01)

Update on the Treatment of Metastatic Urothelial Carcinoma
gan: Nedal Bukhari, et al.
Cyhoeddwyd: (2018-01-01)

Metastatic urothelial carcinoma
gan: Elisabeth Gómez-Moyano, et al.
Cyhoeddwyd: (2021-08-01)

Comparative study of the radiosensitising and cell cycle effects of vinflunine and vinorelbine, <it>in vitro</it>
gan: Pattyn Greet GO, et al.
Cyhoeddwyd: (2008-02-01)

Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma
gan: Inokuchi J, et al.
Cyhoeddwyd: (2019-05-01)

Latin American Consensus for the Evaluation and Treatment of Patients With Metastatic/Locally Advanced Urothelial Carcinoma
gan: Ray Manneh Kopp, et al.
Cyhoeddwyd: (2024-01-01)

Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy
gan: Tassinari E, et al.
Cyhoeddwyd: (2022-06-01)

Efficacy of pembrolizumab rechallenge for metastatic urothelial carcinoma
gan: Nobutaka Nishimura, et al.
Cyhoeddwyd: (2022-09-01)

Association between antibiotics and treatment efficacy in metastatic urothelial carcinoma patients
gan: Avery Braun, et al.
Cyhoeddwyd: (2025-02-01)

Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis
gan: Keren Rouvinov, et al.
Cyhoeddwyd: (2023-05-01)

Denosumab for the Treatment of Refractory Hypercalcemia in Metastatic Parathyroid Carcinoma
gan: Saori Itoshima, MD, et al.
Cyhoeddwyd: (2015-01-01)

Brazilian consensus in muscle-invasive and metastatic urothelial carcinoma
gan: Andrey Soares, et al.
Cyhoeddwyd: (2020-01-01)

Genomic Profiling and Molecular Characterisation of Metastatic Urothelial Carcinoma
gan: Gaetano Pezzicoli, et al.
Cyhoeddwyd: (2024-03-01)

Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually?
gan: Brigida Anna Maiorano, et al.
Cyhoeddwyd: (2023-09-01)

Myelodysplastic syndrome occurring after enfortumab vedotin treatment for metastatic urothelial carcinoma
gan: Kazuki Yanagida, et al.
Cyhoeddwyd: (2024-07-01)

Immunotherapy in the Treatment of Metastatic Urothelial Carcinoma at a Tertiary Referral Center in Portugal
gan: Vasco Quaresma, et al.
Cyhoeddwyd: (2023-02-01)

Severe cutaneous drug toxicity following enfortumab vedotin treatment for metastatic urothelial carcinoma
gan: Christina D. Enescu, BS, et al.
Cyhoeddwyd: (2022-03-01)

Concordance of plasmatic circulating DNA and matched metastatic tissue in metastatic urothelial carcinoma
gan: I. Duquesne, et al.
Cyhoeddwyd: (2020-07-01)

Non–Muscle Invasive Papillary Urothelial Carcinoma Metastatic to the Mandible
gan: Noah Frydenlund MS, et al.
Cyhoeddwyd: (2018-10-01)

Metastatic anal cloacogenic cell carcinoma misdiagnosed as urothelial carcinoma with long survival
gan: Burak Bilgin, et al.
Cyhoeddwyd: (2017-07-01)

Treatment Patterns for Metastatic Urothelial Carcinoma Across Eight Mexican Centers: The ALEBRIJE Study
gan: Evelyn Lilian Beas-Lozano, et al.
Cyhoeddwyd: (2025-01-01)

A case of acute lymphocytic gastritis related to treatment with pembrolizumab for metastatic urothelial carcinoma
gan: Yousuke Fukiishi, et al.
Cyhoeddwyd: (2023-03-01)

Metastatic urothelial carcinoma in multiple appendicular muscles of a cat
gan: Eduardo M Hernández, et al.
Cyhoeddwyd: (2025-01-01)

Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
gan: Zhiying Shao, et al.
Cyhoeddwyd: (2016-10-01)

Unusual Duodenal Ulcer: Metastatic Urothelial Carcinoma of the Renal Pelvis
gan: Yoo Dong Won, et al.
Cyhoeddwyd: (2023-07-01)

Cutaneous metastatic implantation of ureteric urothelial carcinoma to the glans and prepuce
gan: G.N. Weeratunga
Cyhoeddwyd: (2023-03-01)

Biomarkers of the Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma
gan: Siteng Chen, et al.
Cyhoeddwyd: (2020-08-01)

Progress in immune checkpoint inhibitor-based combined regimens in the treatment of metastatic urothelial carcinoma
gan: Liu Jianbing, Yue Zhongjin, Shang Panfeng, Liu Yating, Chang Hong
Cyhoeddwyd: (2023-09-01)

Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma
gan: Ping Hu, et al.
Cyhoeddwyd: (2024-03-01)

PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion
gan: Tämer El Saadany, et al.
Cyhoeddwyd: (2024-08-01)

Plasmacytoid Urothelial Carcinoma of the Bladder Metastatic to the Stomach: A Case Report
gan: Philippe Nabbout, et al.
Cyhoeddwyd: (2012-01-01)

Urothelial Carcinoma of the Bladder Metastatic to Bone Marrow Presenting as Isolated Thrombocytopenia
gan: Robert C. Chan, et al.
Cyhoeddwyd: (2007-01-01)

Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
gan: Marco Audisio, et al.
Cyhoeddwyd: (2022-05-01)

Real-life data of Atezolizumab in urothelial carcinoma, second-line metastatic disease
gan: L.F. Sánchez-Cousido, et al.
Cyhoeddwyd: (2020-11-01)